EvoPlus
Board
2 directors, last change in 2025Statutory director
since 14-06-2023
term without a fixed end
earlier manager, until 21-06-2023
listed in the 2025 annual accounts, filed on 31-07-2026
Director (not named in the articles), permanent representative Jacob Van de Moortel
since 11-02-2025
term without a fixed end
listed in the 2025 annual accounts, filed on 31-07-2026
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- Each director alonedeed of 21-06-2023
Permanent representatives 1
Mandates through the years
2 names, the dashed line is todayMARCHAND Pieter Daniel Eric
Statutory director
Statutory director
BV THEA
Director (not named in the articles)
Director (not named in the articles)
BoardEarliermandate already running before its first mention
Mandates as a list
- MARCHAND Pieter Daniel Eric
- Statutory director, since before 31-12-2021
- Manager, until 21-06-2023
- BV THEA
- Director (not named in the articles), since before 31-12-2024
Control
80%
This company
EvoPlus
Equity €106,798
Profit €164,592 in 2025
Further up the chainVM HOLD 54%Vande Moortel Services 75%
Capital
- Contribution
- €13,330
- Source
- 2025 annual accounts
Owners through the years
as the annual accounts name themSource: lists of holdings in the owners' accounts
Articles of association
deed of 21-06-2023 (in Dutch)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- At least 1 director
- Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
- “Helft overdrager,helft koper(s) naar evenredigheid aantal aandelen, elke overdracht onder levenden ten bezwarende of kosteloze…”
Shareholders
2 ownersOwners 2
- TheaparentEquity €6.3m Profit of €345,837 in 2025 (loss of €57,028 in 2024)Sourceaccounts Thea 202580%
- Equity €1.7m Profit of €426,134 in 2025 (profit of €456,627 in 2024)Sourceaccounts E³O 31-03-202535%